Relay Therapeutics stock surges on vascular anomalies trial data

Relay Therapeutics stock has experienced a significant surge following the release of positive trial data for its treatment of vascular anomalies. The data showed promising results in addressing the condition, leading to increased investor confidence. The stock price has risen in response to the encouraging trial outcomes.